Exact Mass: 339.1582836

Exact Mass Matches: 339.1582836

Found 500 metabolites which its exact mass value is equals to given mass value 339.1582836, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Sinactin

16,17-dimethoxy-5,7-dioxa-1-azapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-3(11),4(8),9,14,16,18-hexaene

C20H21NO4 (339.14705060000006)


Sinactine is an alkaloid. Sinactine is a natural product found in Fumaria capreolata, Fumaria muralis, and other organisms with data available. Tetrahydroepiberberine is a isoquinoline alkaloid isolated from Corydalis impatiens (Pall). Tetrahydroepiberberine has antifungal and selective inhibition against the PI-3 virus activities[1]. Tetrahydroepiberberine is a isoquinoline alkaloid isolated from Corydalis impatiens (Pall). Tetrahydroepiberberine has antifungal and selective inhibition against the PI-3 virus activities[1].

   

Dicentrine

(12S)-16,17-dimethoxy-11-methyl-3,5-dioxa-11-azapentacyclo[10.7.1.02,6.08,20.014,19]icosa-1(20),2(6),7,14,16,18-hexaene

C20H21NO4 (339.14705060000006)


Dicentrine is an aporphine alkaloid. Dicentrine is a natural product found in Cissampelos pareira, Stephania abyssinica, and other organisms with data available. Dicentrine is an anticancer compound isolated from Lindera, a species of flowering plants. Dicentrine is a natural product isolated from the plant Stephania epigaea Lo with antihypertensive effect. Dicentrine is an α1-adrenoceptor antagonist which has effective against human hyperplastic prostates[1].

   

Canadine

(1S)-16,17-dimethoxy-5,7-dioxa-13-azapentacyclo[11.8.0.02,10.04,8.015,20]henicosa-2,4(8),9,15(20),16,18-hexaene

C20H21NO4 (339.14705060000006)


(S)-canadine is the (S)-enantiomer of canadine. It has a role as a plant metabolite. It is an an (S)-7,8,13,14-tetrahydroprotoberberine and a canadine. It is functionally related to a (S)-nandinine. It is an enantiomer of a (R)-canadine. (S)-Canadine is a natural product found in Hydrastis canadensis, Corydalis turtschaninovii, and other organisms with data available. The (S)-enantiomer of canadine. relative retention time with respect to 9-anthracene Carboxylic Acid is 0.721 D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators relative retention time with respect to 9-anthracene Carboxylic Acid is 0.718 Tetrahydroberberine is an isoquinoline alkaloid isolated from Corydalis Corydalis, with uM-level affinity for D2 and 5-HT1A receptors. Tetrahydroberberine is a different kind of living thing that can be extended and divided into parts. Tetrahydroberberine is a kind of effective D2 receptor antagonistic force. Tetrahydroberberine has the ability to strengthen the stomach and relieve the pressure on the stomach[1][2][3]. Tetrahydroberberine is an isoquinoline alkaloid isolated from Corydalis Corydalis, with uM-level affinity for D2 and 5-HT1A receptors.

   

Papaverine

1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy isoquinoline

C20H21NO4 (339.14705060000006)


Papaverine is an alkaloid found in opium but not closely related to the other opium alkaloids in its structure or pharmacological actions. It is a direct-acting smooth muscle relaxant used in the treatment of impotence and as a vasodilator, especially for cerebral vasodilation. The mechanism of its pharmacological actions is not clear, but it apparently can inhibit phosphodiesterases and it may have direct actions on calcium channels. [PubChem]. A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03A - Drugs for functional gastrointestinal disorders > A03AD - Papaverine and derivatives G - Genito urinary system and sex hormones > G04 - Urologicals > G04B - Urologicals > G04BE - Drugs used in erectile dysfunction D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids C78274 - Agent Affecting Cardiovascular System > C29707 - Vasodilating Agent D004791 - Enzyme Inhibitors > D010726 - Phosphodiesterase Inhibitors D000089162 - Genitourinary Agents > D064804 - Urological Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents C471 - Enzyme Inhibitor > C744 - Phosphodiesterase Inhibitor CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 2252 Alkaloid from Papaver somniferum (opium poppy)

   

Nalmefene

NALMEFENE-HCl

C21H25NO3 (339.18343400000003)


N - Nervous system > N07 - Other nervous system drugs > N07B - Drugs used in addictive disorders > N07BB - Drugs used in alcohol dependence D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D009292 - Narcotic Antagonists C78272 - Agent Affecting Nervous System > C681 - Opiate Antagonist

   

Perazine

10-[3-(4-methylpiperazin-1-yl)propyl]-10H-phenothiazine

C20H25N3S (339.176909)


N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AB - Phenothiazines with piperazine structure D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C66883 - Dopamine Antagonist

   

Nantenine

O-Methyl domesticine

C20H21NO4 (339.14705060000006)


A natural product found in Corydalis cava and Nandina domestica. Annotation level-1

   

Eschscholtzidine

(5S)-5,6,11,12-Tetrahydro-8,9-dimethoxy-14-methyl-benzo[5,6]cycloocta[1,2-f]-1,3-benzodioxol-5,11-imine

C20H21NO4 (339.14705060000006)


A heteropentacyclic isoquinoline alkaloid having a tertiary amino bridging group.

   

Tetraphenylphosphonium

Tetraphenylphosphonium

C24H20P+ (339.13025500000003)


D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents D000970 - Antineoplastic Agents

   

Xamoterol

Xamoterol hemifumarate

C16H25N3O5 (339.179412)


C - Cardiovascular system > C01 - Cardiac therapy > C01C - Cardiac stimulants excl. cardiac glycosides C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists Same as: D06328

   

NCIOpen2_009010

3-(2-Propenyloxy)estra-1,3,5(10)-triene-16,17-dione 16-oxime

C21H25NO3 (339.18343400000003)


   

Phenoxybenzamine HCl

Phenoxybenzamine hydrochloride

C18H23Cl2NO (339.1156608)


C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents Phenoxybenzamine hydrochloride is a nonselective, irreversible, orally active α-adrenoceptor antagonist that is commonly used for the research of hypertension, specifically caused by pheochromocytoma. Phenoxybenzamine hydrochloride also shows antitumor activity[1][2].

   

Methylergonovine

Methylergometrine

C20H25N3O2 (339.194667)


G - Genito urinary system and sex hormones > G02 - Other gynecologicals > G02A - Uterotonics > G02AB - Ergot alkaloids C78272 - Agent Affecting Nervous System > C47795 - CNS Stimulant D012102 - Reproductive Control Agents > D010120 - Oxytocics

   

(R)-Canadine

(R)-Canadine

C20H21NO4 (339.14705060000006)


D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators A canadine which has R configuration.

   

Moguisteine

Moguisteine

C16H21NO5S (339.1140376)


C78273 - Agent Affecting Respiratory System > C74536 - Mucolytic Agent

   

RAD51 inhibitor B02

RAD51 inhibitor B02

C22H17N3O (339.1371552)


   

Canadine

(1S)-16,17-dimethoxy-5,7-dioxa-13-azapentacyclo[11.8.0.0^{2,10.0^{4,8.0^{15,20]henicosa-2,4(8),9,15(20),16,18-hexaene

C20H21NO4 (339.14705060000006)


Canadine is a berberine alkaloid that is 5,8,13,13a-tetrahydro-6H-[1,3]dioxolo[4,5-g]isoquino[3,2-a]isoquinoline substituted by methoxy groups at positions 9 and 10. It is a berberine alkaloid, an organic heteropentacyclic compound, an aromatic ether and an oxacycle. Canadine is a natural product found in Glaucium squamigerum, Hydrastis canadensis, and other organisms with data available. A berberine alkaloid that is 5,8,13,13a-tetrahydro-6H-[1,3]dioxolo[4,5-g]isoquino[3,2-a]isoquinoline substituted by methoxy groups at positions 9 and 10. D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators Tetrahydroberberine is an isoquinoline alkaloid isolated from Corydalis Corydalis, with uM-level affinity for D2 and 5-HT1A receptors. Tetrahydroberberine is a different kind of living thing that can be extended and divided into parts. Tetrahydroberberine is a kind of effective D2 receptor antagonistic force. Tetrahydroberberine has the ability to strengthen the stomach and relieve the pressure on the stomach[1][2][3]. Tetrahydroberberine is an isoquinoline alkaloid isolated from Corydalis Corydalis, with uM-level affinity for D2 and 5-HT1A receptors.

   

Methylergonovine

(4R,7R)-N-[(2S)-1-hydroxybutan-2-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),2,9,12,14-pentaene-4-carboxamide

C20H25N3O2 (339.194667)


Methylergonovine is only found in individuals that have used or taken this drug. It is a homolog of ergonovine containing one more CH2 group. (Merck Index, 11th ed)Methylergonovine acts directly on the smooth muscle of the uterus and increases the tone, rate, and amplitude of rhythmic contractions through binding and the resultant antagonism of the dopamine D1 receptor. Thus, it induces a rapid and sustained tetanic uterotonic effect which shortens the third stage of labor and reduces blood loss. G - Genito urinary system and sex hormones > G02 - Other gynecologicals > G02A - Uterotonics > G02AB - Ergot alkaloids C78272 - Agent Affecting Nervous System > C47795 - CNS Stimulant D012102 - Reproductive Control Agents > D010120 - Oxytocics

   

N-Methoxycarbonyl-N-nornuciferine

Methyl 15,16-dimethoxy-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2,4,6,13,15-hexaene-10-carboxylic acid

C20H21NO4 (339.14705060000006)


N-Methoxycarbonyl-N-nornuciferine is found in alcoholic beverages. N-Methoxycarbonyl-N-nornuciferine is an alkaloid from Rollinia mucosa (biriba). Alkaloid from Rollinia mucosa (biriba). N-Methoxycarbonyl-N-nornuciferine is found in alcoholic beverages and fruits.

   

Dehydropipernonaline

(2E,4E,8E)-9-(2H-1,3-benzodioxol-5-yl)-1-(piperidin-1-yl)nona-2,4,8-trien-1-one

C21H25NO3 (339.18343400000003)


Dehydropipernonaline is found in herbs and spices. Dehydropipernonaline is isolated from fruits of Piper longum (long pepper). Isolated from fruits of Piper longum (long pepper). Dehydropipernonaline is found in herbs and spices and pepper (spice).

   

Litebamine

9,13-dimethoxy-5-methyl-5-azatetracyclo[8.8.0.0²,⁷.0¹¹,¹⁶]octadeca-1,7,9,11,13,15,17-heptaene-8,14-diol

C20H21NO4 (339.14705060000006)


Litebamine is found in fruits. Litebamine is an alkaloid from Litsea cubeba (mountain pepper). Alkaloid from Litsea cubeba (mountain pepper). Litebamine is found in fruits.

   

1-Hydroxyrutacridone epoxide

1,5-dihydroxy-11-methyl-2-(2-methyloxiran-2-yl)-1H,2H,6H,11H-furo[2,3-c]acridin-6-one

C19H17NO5 (339.1106672)


1-Hydroxyrutacridone epoxide is an alkaloid from the callus tissue of Ruta graveolens (rue). Alkaloid from the callus tissue of Ruta graveolens (rue).

   

Rutagravine

6,11-dihydroxy-6,20-dimethyl-4,8-dioxa-20-azapentacyclo[10.8.0.0²,⁹.0³,⁷.0¹⁴,¹⁹]icosa-1(12),2(9),10,14,16,18-hexaen-13-one

C19H17NO5 (339.1106672)


Rutagravine is found in herbs and spices. Rutagravine is an alkaloid from the callus tissue of Ruta graveolens (rue). Alkaloid from the callus tissue of Ruta graveolens (rue). Rutagravine is found in herbs and spices.

   

5-Hydroxytryptophol glucuronide

(2R,3R,4S,5S,6R)-2-{[3-(2-hydroxyethyl)-1H-indol-5-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C16H21NO7 (339.13179560000003)


5-Hydroxytryptophol glucuronide (GTOL) is the major excretion form of 5-hydroxytryptophol (5-HTOL), a minor serotonin metabolite under normal conditions. Because the concentration of 5-HTOL is markedly increased following consumption of alcohol, measurement of 5-HTOL is used as a sensitive biomarker for detection of recent alcohol intake. PMID: 15664340. 5-Hydroxytryptophol glucuronide provided higher diagnostic specificity and sensitivity than 5-hydroxytryptophol. PMID: 17112495. 5-Hydroxytryptophol glucuronide (GTOL) is the major excretion form of 5-hydroxytryptophol (5-HTOL), a minor serotonin metabolite under normal conditions. Because the concentration of 5-HTOL is markedly increased following consumption of alcohol, measurement of 5-HTOL is used as a sensitive biomarker for detection of recent alcohol intake. PMID: 15664340

   

7-Hydroxygliclazide

N-{5-hydroxy-octahydrocyclopenta[c]pyrrol-2-yl}-N-(4-methylbenzenesulphonyl)carbamimidic acid

C15H21N3O4S (339.1252706)


7-Hydroxygliclazide is only found in individuals that have used or taken Gliclazide. 7-Hydroxygliclazide is a metabolite of Gliclazide. 7-hydroxygliclazide belongs to the family of Benzenesulfonamides. These are organic compounds containing a sulfonamide group that is S-linked to a benzene ring.

   

6-Hydroxygliclazide

N-{4-hydroxy-octahydrocyclopenta[c]pyrrol-2-yl}-N-(4-methylbenzenesulphonyl)carbamimidic acid

C15H21N3O4S (339.1252706)


6-Hydroxygliclazide is only found in individuals that have used or taken Gliclazide. 6-Hydroxygliclazide is a metabolite of Gliclazide. 6-hydroxygliclazide belongs to the family of Benzenesulfonamides. These are organic compounds containing a sulfonamide group that is S-linked to a benzene ring.

   

Methylhydroxygliclazide

N-[4-(Hydroxymethyl)benzenesulphonyl]-n-{octahydrocyclopenta[c]pyrrol-2-yl}carbamimidic acid

C15H21N3O4S (339.1252706)


Methylhydroxygliclazide is only found in individuals that have used or taken Gliclazide. Methylhydroxygliclazide is a metabolite of Gliclazide. Methylhydroxygliclazide belongs to the family of Benzenesulfonamides. These are organic compounds containing a sulfonamide group that is S-linked to a benzene ring.

   

20-Hydroxyrutacridone epoxide

5-hydroxy-2-[2-(hydroxymethyl)oxiran-2-yl]-11-methyl-1H,2H,6H,11H-furo[2,3-c]acridin-6-one

C19H17NO5 (339.1106672)


20-Hydroxyrutacridone epoxide is found in herbs and spices. 20-Hydroxyrutacridone epoxide is an alkaloid from the roots and callus tissue cultures of Ruta graveolens (rue). Alkaloid from the roots and callus tissue cultures of Ruta graveolens (rue). 20-Hydroxyrutacridone epoxide is found in herbs and spices.

   

(3E,5E,8Z)-Deca-3,5,8-trienedioylcarnitine

3-[(9-carboxynona-3,5,8-trienoyl)oxy]-4-(trimethylazaniumyl)butanoate

C17H25NO6 (339.168179)


(3E,5E,8Z)-Deca-3,5,8-trienedioylcarnitine is an acylcarnitine. More specifically, it is an (3E,5E,8Z)-deca-3,5,7-trienedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (3E,5E,8Z)-Deca-3,5,8-trienedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine (3E,5E,8Z)-Deca-3,5,8-trienedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

Deca-2,5,8-trienedioylcarnitine

3-[(9-carboxynona-2,5,8-trienoyl)oxy]-4-(trimethylazaniumyl)butanoate

C17H25NO6 (339.168179)


Deca-2,5,8-trienedioylcarnitine is an acylcarnitine. More specifically, it is an deca-2,5,8-trienedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. Deca-2,5,8-trienedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine Deca-2,5,8-trienedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

Deca-3,5,7-trienedioylcarnitine

3-[(9-carboxynona-3,5,7-trienoyl)oxy]-4-(trimethylazaniumyl)butanoate

C17H25NO6 (339.168179)


Deca-3,5,7-trienedioylcarnitine is an acylcarnitine. More specifically, it is an deca-3,5,7-trienedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. Deca-3,5,7-trienedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine Deca-3,5,7-trienedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

Deca-4,6,8-trienedioylcarnitine

3-[(9-carboxynona-4,6,8-trienoyl)oxy]-4-(trimethylazaniumyl)butanoate

C17H25NO6 (339.168179)


Deca-4,6,8-trienedioylcarnitine is an acylcarnitine. More specifically, it is an deca-4,6,8-trienedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. Deca-4,6,8-trienedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine Deca-4,6,8-trienedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

(+/-)-Dicentrine

16,17-dimethoxy-11-methyl-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,14(19),15,17-hexaene

C20H21NO4 (339.14705060000006)


(s)-dicentrine is a member of the class of compounds known as aporphines. Aporphines are quinoline alkaloids containing the dibenzo[de,g]quinoline ring system or a dehydrogenated derivative thereof (s)-dicentrine is practically insoluble (in water) and a very strong basic compound (based on its pKa). (s)-dicentrine can be found in barley, which makes (s)-dicentrine a potential biomarker for the consumption of this food product. Dicentrine is a natural product isolated from the plant Stephania epigaea Lo with antihypertensive effect. Dicentrine is an α1-adrenoceptor antagonist which has effective against human hyperplastic prostates[1].

   

(R)-Canadine

16,17-dimethoxy-5,7-dioxa-13-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁵,²⁰]henicosa-2,4(8),9,15,17,19-hexaene

C20H21NO4 (339.14705060000006)


Tetrahydroberberine is an isoquinoline alkaloid isolated from Corydalis Corydalis, with uM-level affinity for D2 and 5-HT1A receptors. Tetrahydroberberine is a different kind of living thing that can be extended and divided into parts. Tetrahydroberberine is a kind of effective D2 receptor antagonistic force. Tetrahydroberberine has the ability to strengthen the stomach and relieve the pressure on the stomach[1][2][3]. Tetrahydroberberine is an isoquinoline alkaloid isolated from Corydalis Corydalis, with uM-level affinity for D2 and 5-HT1A receptors.

   

N(G)-Nitroarginine-4-nitroanilide

2-amino-5-{[amino(nitroamino)methylidene]amino}-N-(4-nitrophenyl)pentanamide

C12H17N7O5 (339.1291112)


   

7-[(4-Fluorophenyl)methoxy]-2,3-dimethyl-1-[(2-methylcyclopropyl)methyl]pyrrolo[2,3-d]pyridazine

7-[(4-fluorophenyl)methoxy]-2,3-dimethyl-1-[(2-methylcyclopropyl)methyl]-1H-pyrrolo[2,3-d]pyridazine

C20H22FN3O (339.1746814)


   

Alogliptin

2-{[6-(3-aminopiperidin-1-yl)-3-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl]methyl}benzonitrile

C18H21N5O2 (339.1695166)


   

Bursin

2,6-Diamino-N-(1-{[(C-hydroxycarbonimidoyl)methyl]-C-hydroxycarbonimidoyl}-2-(1H-imidazol-5-yl)ethyl)hexanimidate

C14H25N7O3 (339.20187799999997)


   

Bursopoietin

2,6-Diamino-N-(1-{[(C-hydroxycarbonimidoyl)methyl]-C-hydroxycarbonimidoyl}-2-(4H-imidazol-4-yl)ethyl)hexanimidate

C14H25N7O3 (339.20187799999997)


   

n2-(1-Carboxyethyl)-2'-deoxyguanosine

2-({6-hydroxy-9-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-3,9-dihydro-2H-purin-2-ylidene}amino)propanoate

C13H17N5O6 (339.1178782)


   

(2s)-1-[1-(4-Phenylbutanoyl)-L-Prolyl]pyrrolidine-2-Carbonitrile

1-[1-(4-phenylbutanoyl)pyrrolidine-2-carbonyl]pyrrolidine-2-carbonitrile

C20H25N3O2 (339.194667)


   

Edivoxetine

(R)-2-(5-Fluoro-2-methoxyphenyl)-1-((S)-morpholin-2-yl)-1-(tetrahydro-2H-pyran-4-yl)ethanol

C18H26FNO4 (339.18457680000006)


   

Loxoribine

2-amino-9-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-7-(prop-2-en-1-yl)-6,7,8,9-tetrahydro-1H-purine-6,8-dione

C13H17N5O6 (339.1178782)


   

1',3'-Dimethylspiro[1,3,4,6,7,12b-hexahydro-[1]benzofuro[2,3-a]quinolizine-2,4'-1,3-diazinane]-2'-one

1,5-dimethyl-17-oxa-7-azaspiro[1,5-diazinane-2,4-tetracyclo[8.7.0.0^{2,7}.0^{11,16}]heptadecane]-1(10),11,13,15-tetraen-6-one

C20H25N3O2 (339.194667)


D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists

   

Moguisteine

Ethyl 3-{2-[(2-methoxyphenoxy)methyl]-1,3-thiazolidin-3-yl}-3-oxopropanoic acid

C16H21NO5S (339.1140376)


   

Nalmefene

4-(cyclopropylmethyl)-14-methylidene-12-oxa-4-azapentacyclo[9.6.1.0^{1,13}.0^{5,17}.0^{7,18}]octadeca-7(18),8,10-triene-10,17-diol

C21H25NO3 (339.18343400000003)


   

Panipenem

3-[(1-ethanimidoylpyrrolidin-3-yl)sulfanyl]-6-(1-hydroxyethyl)-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid

C15H21N3O4S (339.1252706)


   

16,17-Dimethoxy-6,8-dioxa-1-azapentacyclo[11.8.0.03,11.05,9.014,19]henicosa-3,5(9),10,14,16,18-hexaene

16,17-dimethoxy-6,8-dioxa-1-azapentacyclo[11.8.0.0^{3,11}.0^{5,9}.0^{14,19}]henicosa-3,5(9),10,14,16,18-hexaene

C20H21NO4 (339.14705060000006)


   

L-CBN

(12R)-15,16-dimethoxy-11-methyl-3,5-dioxa-11-azapentacyclo[10.7.1.0^{2,6.0^{8,20.0^{14,19]icosa-1(20),2(6),7,14(19),15,17-hexaene

C20H21NO4 (339.14705060000006)


Crebanine is a natural product found in Stephania abyssinica, Stephania cephalantha, and Stephania hainanensis with data available. Crebanine, an alkaloid from Stephania venosa, induces G1 arrest and apoptosis in human cancer cells. Crebanine exhibits anti-inflammatory activity via suppressing MAPKs and Akt signaling. Crebanine also possesses antiarrhythmic effect[1][2]. Crebanine, an alkaloid from Stephania venosa, induces G1 arrest and apoptosis in human cancer cells. Crebanine exhibits anti-inflammatory activity via suppressing MAPKs and Akt signaling. Crebanine also possesses antiarrhythmic effect[1][2]. Crebanine, an alkaloid from Stephania venosa, induces G1 arrest and apoptosis in human cancer cells. Crebanine exhibits anti-inflammatory activity via suppressing MAPKs and Akt signaling. Crebanine also possesses antiarrhythmic effect[1][2].

   

Tox21_302226

BENZENEACETIC ACID, ALPHA-(HYDROXYMETHYL)-, 9-METHYL-3-OXA-9-AZATRICYCLO(3.3.1.0(SUP 2,4))NON-7-YL ESTER, HYDROCHLORIDE, (7(S)-(1-.ALPHA.,2-.BETA.,4-.BETA.,5-.ALPHA.,7-.BETA.))-

C17H21NO4.HCl (339.1237282)


   
   
   
   
   
   
   

2-Dehydrodeacetylheterophylloidine

2-Dehydrodeacetylheterophylloidine

C21H25NO3 (339.18343400000003)


   

Oliverine

O-Methyloliveridine

C20H21NO4 (339.14705060000006)


   
   

8-Oxotetrahydrothalifendine

8-Oxotetrahydrothalifendine

C19H17NO5 (339.1106672)


   
   
   

12-Hydroxycrychine

(-)-12-Hydroxycrychine

C19H17NO5 (339.1106672)


   
   
   
   
   
   
   

(-)-13-beta-Hydroxystylopine

(-)-13-beta-Hydroxystylopine

C19H17NO5 (339.1106672)


   
   
   
   
   
   

O=C(OC)CCCN1C(=O)c2c(-c3c1cccc3)cc1OCOc1c2

O=C(OC)CCCN1C(=O)c2c(-c3c1cccc3)cc1OCOc1c2

C19H17NO5 (339.1106672)


   
   

7-Angeloyl-9-(2,3-dihydroxybutyryl)heliotridine

7-Angeloyl-9-(2,3-dihydroxybutyryl)heliotridine

C17H25NO6 (339.168179)


   
   

(14R)-Reframidine N-oxide

(14R)-Reframidine N-oxide

C19H17NO5 (339.1106672)


   
   

Eximine

O,N-Dimethyllitseferine

C20H21NO4 (339.14705060000006)


Dicentrine is a natural product isolated from the plant Stephania epigaea Lo with antihypertensive effect. Dicentrine is an α1-adrenoceptor antagonist which has effective against human hyperplastic prostates[1].

   
   

3-(2-hydroxyethyl)-1H-indole-5-O-beta-D-glucopyranoside

3-(2-hydroxyethyl)-1H-indole-5-O-beta-D-glucopyranoside

C16H21NO7 (339.13179560000003)


   

2,6-bis(4-methoxyphenyl)-3,5-dimethylpiperidin-4-one

2,6-bis(4-methoxyphenyl)-3,5-dimethylpiperidin-4-one

C21H25NO3 (339.18343400000003)


   
   
   
   

[[1-amino-3-(5-methyl-2-oxo-1,3-benzoxazol-3-yl)propylidene]amino] benzoate

[[1-amino-3-(5-methyl-2-oxo-1,3-benzoxazol-3-yl)propylidene]amino] benzoate

C18H17N3O4 (339.1219002)


   
   
   
   
   
   

(+-)-Apocavidin|(+-)-apocavidine|(+/-)-apocavidine|9-methoxy-6t-methyl-(6ar)-6,11,12,14-tetrahydro-6aH-[1,3]dioxolo[4,5-h]isoquino[2,1-b]isoquinolin-8-ol|apocavidine

(+-)-Apocavidin|(+-)-apocavidine|(+/-)-apocavidine|9-methoxy-6t-methyl-(6ar)-6,11,12,14-tetrahydro-6aH-[1,3]dioxolo[4,5-h]isoquino[2,1-b]isoquinolin-8-ol|apocavidine

C20H21NO4 (339.14705060000006)


   

(+/-)-chilenamine|(??)-Chilenamine|9,10-dimethoxy-5,8,12b,13-tetrahydro-6H-[1,3]dioxolo[4,5:4,5]benzo[1,2:4,5]azepino[2,1-a]isoindole|chilenamine

(+/-)-chilenamine|(??)-Chilenamine|9,10-dimethoxy-5,8,12b,13-tetrahydro-6H-[1,3]dioxolo[4,5:4,5]benzo[1,2:4,5]azepino[2,1-a]isoindole|chilenamine

C20H21NO4 (339.14705060000006)


   
   
   

(6Z)-6-{[2-(1,1-dimethylprop-2-en-1-yl)-1H-indol-3-yl]methylidene}-3-hydroxy-3-methylpiperazine-2,5-dione|variecolorin O

(6Z)-6-{[2-(1,1-dimethylprop-2-en-1-yl)-1H-indol-3-yl]methylidene}-3-hydroxy-3-methylpiperazine-2,5-dione|variecolorin O

C19H21N3O3 (339.1582836)


   

Acetoxycycloheximide

Acetoxycycloheximide

C17H25NO6 (339.168179)


   

(+-)-epiapocavidine|9-methoxy-13-methyl-5,8,13,13a-tetrahydro-6H-[1,3]dioxolo[4,5-g]isoquino[3,2-a]isoquinolin-10-ol|Epiapocavidin

(+-)-epiapocavidine|9-methoxy-13-methyl-5,8,13,13a-tetrahydro-6H-[1,3]dioxolo[4,5-g]isoquino[3,2-a]isoquinolin-10-ol|Epiapocavidin

C20H21NO4 (339.14705060000006)


   
   
   

(+-)-amurensinine|7,8-dimethoxy-13-methyl-10,11-dihydro-5H-11c,5r-azaethano-benzo[4,5]cyclohepta[1,2:4,5]benzo[1,2-d][1,3]dioxole|Amurensinin|Amurensinine

(+-)-amurensinine|7,8-dimethoxy-13-methyl-10,11-dihydro-5H-11c,5r-azaethano-benzo[4,5]cyclohepta[1,2:4,5]benzo[1,2-d][1,3]dioxole|Amurensinin|Amurensinine

C20H21NO4 (339.14705060000006)


   
   
   

(+)-N-formylhernangerine

(+)-N-formylhernangerine

C19H17NO5 (339.1106672)


   
   
   
   

9-O-(erythro-2-hydroxy-2-methyl-3-tigloyloxy-butyryl)-(-)-trachelanthamidine|minalobine O

9-O-(erythro-2-hydroxy-2-methyl-3-tigloyloxy-butyryl)-(-)-trachelanthamidine|minalobine O

C18H29NO5 (339.20456240000004)


   

aristololactam CIII

aristololactam CIII

C19H17NO5 (339.1106672)


   

5-hydroxynoracronycine alcohol

5-hydroxynoracronycine alcohol

C19H17NO5 (339.1106672)


   
   
   

desulfo-5-methylsulfanylpentyl GL|desulfoglucoberteroin|DS-GBE

desulfo-5-methylsulfanylpentyl GL|desulfoglucoberteroin|DS-GBE

C13H25NO5S2 (339.117408)


   

COC1=C(OC)C2=C(C=C(C(OC)=C3)O)C3=CC(N(C)CC3)=C2C3=C1

COC1=C(OC)C2=C(C=C(C(OC)=C3)O)C3=CC(N(C)CC3)=C2C3=C1

C20H21NO4 (339.14705060000006)


   

(+)-11-methoxynornoelistine

(+)-11-methoxynornoelistine

C19H17NO5 (339.1106672)


   
   

N-Ethoxycarbonylethylcrinasiadine

N-Ethoxycarbonylethylcrinasiadine

C19H17NO5 (339.1106672)


   

5,6-dihydro-3,10-dihydroxy-9,11-dimethoxy-8H-dibenzo[a,g]quinolizine-8-one|pendulamine B

5,6-dihydro-3,10-dihydroxy-9,11-dimethoxy-8H-dibenzo[a,g]quinolizine-8-one|pendulamine B

C19H17NO5 (339.1106672)


   

(+-)-Amurensinin|(+-)-Reframin|(+-)-reframine|7,8-dimethoxy-13-methyl-10,11-dihydro-5H-10c,5r-azaethano-benzo[4,5]cyclohepta[1,2:4,5]benzo[1,2-d][1,3]dioxole|Me ether-(??)-Reframoline|Reframin

(+-)-Amurensinin|(+-)-Reframin|(+-)-reframine|7,8-dimethoxy-13-methyl-10,11-dihydro-5H-10c,5r-azaethano-benzo[4,5]cyclohepta[1,2:4,5]benzo[1,2-d][1,3]dioxole|Me ether-(??)-Reframoline|Reframin

C20H21NO4 (339.14705060000006)


   

(S)-11,12-dimethoxy-7-methyl-6a,7,8,9-tetrahydro-6H-benzo[de][1,3]dioxolo[4,5:5,6]benzo[1,2-g]quinoline

(S)-11,12-dimethoxy-7-methyl-6a,7,8,9-tetrahydro-6H-benzo[de][1,3]dioxolo[4,5:5,6]benzo[1,2-g]quinoline

C20H21NO4 (339.14705060000006)


   

2-(7-Methoxy-1,3-benzodioxol-5-yl)-8-methoxy-1-methylquinolin-4(1H)-one

2-(7-Methoxy-1,3-benzodioxol-5-yl)-8-methoxy-1-methylquinolin-4(1H)-one

C19H17NO5 (339.1106672)


   
   
   

(4S,5S,11S)-5-O-(beta-D-Xylopyranosyl)streptazolin

(4S,5S,11S)-5-O-(beta-D-Xylopyranosyl)streptazolin

C16H21NO7 (339.13179560000003)


   
   
   

12,16-dihydroxy-13-methoxy-4,7-dimethyl-14-oxa-4-aza-tricyclo[11.2.1.02,7]hexadec-1-ene-3,8-dione|phyllostictine D

12,16-dihydroxy-13-methoxy-4,7-dimethyl-14-oxa-4-aza-tricyclo[11.2.1.02,7]hexadec-1-ene-3,8-dione|phyllostictine D

C17H25NO6 (339.168179)


   

6beta-Isovaleryloxy-3alpha-tigloyloxy-tropanol-(7beta)

6beta-Isovaleryloxy-3alpha-tigloyloxy-tropanol-(7beta)

C18H29NO5 (339.20456240000004)


   

3-(1,1-Dimethoxy-2-oxoethoxy)-9,10-dihydro-1-methoxy-9-oxo-4-acridinecarboxaldehyde

3-(1,1-Dimethoxy-2-oxoethoxy)-9,10-dihydro-1-methoxy-9-oxo-4-acridinecarboxaldehyde

C19H17NO5 (339.1106672)


   
   

n,n-dimethyl-2-(2,3,4-trimethoxyphenanthren-1-yl)ethanamine

n,n-dimethyl-2-(2,3,4-trimethoxyphenanthren-1-yl)ethanamine

C21H25NO3 (339.18343400000003)


   
   
   
   
   
   
   
   
   
   
   
   
   

Pimelic Diphenylamide 106

N1-(2-aminophenyl)-N7-(4-methylphenyl)-heptanediamide

C20H25N3O2 (339.194667)


   
   
   
   

BML-210

N-(2-aminophenyl)-N-phenyl-octanediamide

C20H25N3O2 (339.194667)


   
   
   
   
   
   
   
   
   
   
   
   

(+)-7-epi-12-hydroxyjasmonoyl-L-isoleucine

(+)-7-epi-12-hydroxyjasmonoyl-L-isoleucine

C18H29NO5 (339.20456240000004)


   
   

Tox21_302226

BENZENEACETIC ACID, ALPHA-(HYDROXYMETHYL)-, 9-METHYL-3-OXA-9-AZATRICYCLO(3.3.1.0(SUP 2,4))NON-7-YL ESTER, HYDROCHLORIDE, (7(S)-(1-.ALPHA.,2-.BETA.,4-.BETA.,5-.ALPHA.,7-.BETA.))-

C17H22ClNO4 (339.1237282000001)


   

Papaverine

Papaverine

C20H21NO4 (339.14705060000006)


A benzylisoquinoline alkaloid that is isoquinoline substituted by methoxy groups at positions 6 and 7 and a 3,4-dimethoxybenzyl group at position 1. It has been isolated from Papaver somniferum. A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03A - Drugs for functional gastrointestinal disorders > A03AD - Papaverine and derivatives G - Genito urinary system and sex hormones > G04 - Urologicals > G04B - Urologicals > G04BE - Drugs used in erectile dysfunction D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids C78274 - Agent Affecting Cardiovascular System > C29707 - Vasodilating Agent D004791 - Enzyme Inhibitors > D010726 - Phosphodiesterase Inhibitors D000089162 - Genitourinary Agents > D064804 - Urological Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents C471 - Enzyme Inhibitor > C744 - Phosphodiesterase Inhibitor Annotation level-1 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.761 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.758

   

Methylergometrine

Methylergometrine

C20H25N3O2 (339.194667)


relative retention time with respect to 9-anthracene Carboxylic Acid is 0.459 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.457 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.450 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.451

   

[3-[2-(2,6-dioxopiperidin-4-yl)-1-hydroxyethyl]-1,5-dimethyl-4-oxocyclohexyl] acetate

NCGC00246789-03![3-[2-(2,6-dioxopiperidin-4-yl)-1-hydroxyethyl]-1,5-dimethyl-4-oxocyclohexyl] acetate

C17H25NO6 (339.168179)


   

1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxyisoquinoline

NCGC00015810-24!1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxyisoquinoline

C20H21NO4 (339.14705060000006)


   
   

[3-[2-(2,6-dioxopiperidin-4-yl)-1-hydroxyethyl]-1,5-dimethyl-4-oxocyclohexyl] acetate [IIN-based on: CCMSLIB00000845926]

NCGC00246789-03![3-[2-(2,6-dioxopiperidin-4-yl)-1-hydroxyethyl]-1,5-dimethyl-4-oxocyclohexyl] acetate [IIN-based on: CCMSLIB00000845926]

C17H25NO6 (339.168179)


   

[3-[2-(2,6-dioxopiperidin-4-yl)-1-hydroxyethyl]-1,5-dimethyl-4-oxocyclohexyl] acetate [IIN-based: Match]

NCGC00246789-03![3-[2-(2,6-dioxopiperidin-4-yl)-1-hydroxyethyl]-1,5-dimethyl-4-oxocyclohexyl] acetate [IIN-based: Match]

C17H25NO6 (339.168179)


   

N2-S-Carboxyethyl-deoxyguanosine

N2-S-Carboxyethyl-deoxyguanosine

C13H17N5O6 (339.1178782)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

N-Didesethylquinagolide

N-Didesethylquinagolide

C16H25N3O3S (339.161654)


   
   
   
   

N-[[(hexahydrocyclopenta[c]pyrrol-2(1H)-yl)amino]carbonyl]-4-(hydroxymethyl)-Benzenesulfonamide

N-[[(hexahydrocyclopenta[c]pyrrol-2(1H)-yl)amino]carbonyl]-4-(hydroxymethyl)-Benzenesulfonamide

C15H21N3O4S (339.1252706)


   

N-((4-hydroxyhexahydrocyclopenta[c]pyrrol-2(1H)-yl)carbamoyl)-4-methylbenzenesulfonamide

N-((4-hydroxyhexahydrocyclopenta[c]pyrrol-2(1H)-yl)carbamoyl)-4-methylbenzenesulfonamide

C15H21N3O4S (339.1252706)


   

N-((5-hydroxyhexahydrocyclopenta[c]pyrrol-2(1H)-yl)carbamoyl)-4-methylbenzenesulfonamide

N-((5-hydroxyhexahydrocyclopenta[c]pyrrol-2(1H)-yl)carbamoyl)-4-methylbenzenesulfonamide

C15H21N3O4S (339.1252706)


   
   

JWH 203

2-(2-chlorophenyl)-1-(1-pentyl-1H-indol-3-yl)-ethanone

C21H22ClNO (339.13898320000004)


   

Abu-Lys-OH

(S)-7-amino-2-(3-ethoxy-4-nitrobenzamido)heptanoic acid

C15H21N3O6 (339.1430286)


   

Lys-Abu-OH

(S)-2-(3-(4-aminobutoxy)-4-nitrobenzamido)pentanoic acid

C15H21N3O6 (339.1430286)


   
   
   

Rutagravine

6,11-dihydroxy-6,20-dimethyl-4,8-dioxa-20-azapentacyclo[10.8.0.0^{2,9}.0^{3,7}.0^{14,19}]icosa-1,9,11,14,16,18-hexaen-13-one

C19H17NO5 (339.1106672)


   

1-Hydroxyrutacridone epoxide

1,5-dihydroxy-11-methyl-2-(2-methyloxiran-2-yl)-1H,2H,6H,11H-furo[2,3-c]acridin-6-one

C19H17NO5 (339.1106672)


   

20-Hydroxyrutacridone epoxide

5-hydroxy-2-[2-(hydroxymethyl)oxiran-2-yl]-11-methyl-1H,2H,6H,11H-furo[2,3-c]acridin-6-one

C19H17NO5 (339.1106672)


   

N-Methoxycarbonyl-N-nornuciferine

methyl 15,16-dimethoxy-10-azatetracyclo[7.7.1.0^{2,7}.0^{13,17}]heptadeca-1(17),2,4,6,13,15-hexaene-10-carboxylate

C20H21NO4 (339.14705060000006)


   

Litebamine

9,13-dimethoxy-5-methyl-5-azatetracyclo[8.8.0.0^{2,7}.0^{11,16}]octadeca-1,7,9,11,13,15,17-heptaene-8,14-diol

C20H21NO4 (339.14705060000006)


   

Dehydropipernonaline

(2E,4E,8E)-9-(2H-1,3-benzodioxol-5-yl)-1-(piperidin-1-yl)nona-2,4,8-trien-1-one

C21H25NO3 (339.18343400000003)


   
   

3-[[2-(4-cyclopentylphenoxy)acetyl]amino]benzoic acid

3-[[2-(4-cyclopentylphenoxy)acetyl]amino]benzoic acid

C20H21NO4 (339.14705060000006)


   

4-Dibenzo[b,f][1,4]thiazepin-11-yl-1-piperazineethanol

4-Dibenzo[b,f][1,4]thiazepin-11-yl-1-piperazineethanol

C19H21N3OS (339.14052560000005)


   

Dodecyl 3-amino-4-chlorobenzoate

Dodecyl 3-amino-4-chlorobenzoate

C19H30ClNO2 (339.196495)


   

1-CBZ-4-(4-CARBOXY-PHENYL)-PIPERIDINE

1-CBZ-4-(4-CARBOXY-PHENYL)-PIPERIDINE

C20H21NO4 (339.14705060000006)


   

Mofezolac

Mofezolac

C19H17NO5 (339.1106672)


D018501 - Antirheumatic Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D016861 - Cyclooxygenase Inhibitors C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D004791 - Enzyme Inhibitors

   

3-[2-oxo-3-(4-propan-2-ylphenoxy)pyrrolidin-1-yl]benzoic acid

3-[2-oxo-3-(4-propan-2-ylphenoxy)pyrrolidin-1-yl]benzoic acid

C20H21NO4 (339.14705060000006)


   
   

N-BOC-4-(P-CHLOROPHENYL)-4-PIPERIDINE CARBOXYLIC ACID

N-BOC-4-(P-CHLOROPHENYL)-4-PIPERIDINE CARBOXYLIC ACID

C17H22ClNO4 (339.1237282000001)


   
   

1-benzyl-3-methyl 6-methoxyindole-1,3-dicarboxylate

1-benzyl-3-methyl 6-methoxyindole-1,3-dicarboxylate

C19H17NO5 (339.1106672)


   

3-N-BOC-AMINO-1-[2-AMINO-1-(3-CHLORO-PHENYL)-ETHYL]-PYRROLIDINE

3-N-BOC-AMINO-1-[2-AMINO-1-(3-CHLORO-PHENYL)-ETHYL]-PYRROLIDINE

C17H26ClN3O2 (339.1713446)


   

3-N-BOC-AMINO-1-[2-AMINO-1-(4-CHLORO-PHENYL)-ETHYL]-PYRROLIDINE

3-N-BOC-AMINO-1-[2-AMINO-1-(4-CHLORO-PHENYL)-ETHYL]-PYRROLIDINE

C17H26ClN3O2 (339.1713446)


   

5-METHOXY-4-(PIPERIDINE-1-CARBONYL)-[1,1-BIPHENYL]-3-CARBOXYLIC ACID

5-METHOXY-4-(PIPERIDINE-1-CARBONYL)-[1,1-BIPHENYL]-3-CARBOXYLIC ACID

C20H21NO4 (339.14705060000006)


   

TERT-BUTYL 3-(3-(BENZYLOXY)PHENYL)AZETIDINE-1-CARBOXYLATE

TERT-BUTYL 3-(3-(BENZYLOXY)PHENYL)AZETIDINE-1-CARBOXYLATE

C21H25NO3 (339.18343400000003)


   

1-(3-(4-AMINOPHENYL)-4,5-DIHYDRO-1H-PYRAZOL-1-YL)-2-(3,4-DIMETHOXYPHENYL)ETHANONE

1-(3-(4-AMINOPHENYL)-4,5-DIHYDRO-1H-PYRAZOL-1-YL)-2-(3,4-DIMETHOXYPHENYL)ETHANONE

C19H21N3O3 (339.1582836)


   

Poly(oxy-1,2-ethandiyl), alpha-decyl-omega-hydroxy-, phosphat, Kaliumsalz

Poly(oxy-1,2-ethandiyl), alpha-decyl-omega-hydroxy-, phosphat, Kaliumsalz

C12H29KO6P+ (339.1338744)


   

(S)-N-DESISOPROPYLPROPRANOLOL

(S)-N-DESISOPROPYLPROPRANOLOL

C19H17NO5 (339.1106672)


   

4-Hexyl-1,1:4,1-terphenyl-4-carbonitrile

4-Hexyl-1,1:4,1-terphenyl-4-carbonitrile

C25H25N (339.198689)


   
   

(3R,4S)-1-BENZOYL-3-((2-METHOXYPROPAN-2-YL)OXY)-4-PHENYLAZETIDIN-2-ONE

(3R,4S)-1-BENZOYL-3-((2-METHOXYPROPAN-2-YL)OXY)-4-PHENYLAZETIDIN-2-ONE

C20H21NO4 (339.14705060000006)


   

tert-butyl 4-tosylpiperidine-1-carboxylate

tert-butyl 4-tosylpiperidine-1-carboxylate

C17H25NO4S (339.15042100000005)


   

(3R,4S)-1-benzoyl-3-(2-ethoxyethoxy)-4-phenyl-2-azetidione

(3R,4S)-1-benzoyl-3-(2-ethoxyethoxy)-4-phenyl-2-azetidione

C20H21NO4 (339.14705060000006)


   

1H-Indole-2-carboxaldehyde,2,3-dihydro-2-hydroxy-1,3,3-trimethyl-,(4-methoxyphenyl)methylhydrazone

1H-Indole-2-carboxaldehyde,2,3-dihydro-2-hydroxy-1,3,3-trimethyl-,(4-methoxyphenyl)methylhydrazone

C20H25N3O2 (339.194667)


   
   
   
   

1-(T-BUTOXYCARBONYL)-4-(2-NITROIMIDAZOL-1-YLACETYL)PIPERAZINE

1-(T-BUTOXYCARBONYL)-4-(2-NITROIMIDAZOL-1-YLACETYL)PIPERAZINE

C14H21N5O5 (339.15426160000004)


   

C-(1-TRITYL-1H-IMIDAZOL-4-YL)-METHYLAMINE

C-(1-TRITYL-1H-IMIDAZOL-4-YL)-METHYLAMINE

C23H21N3 (339.17353860000003)


   

cocaine Hcl

Cocaine hydrochloride

C17H22ClNO4 (339.1237282000001)


D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors > D018765 - Dopamine Uptake Inhibitors D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D000777 - Anesthetics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002317 - Cardiovascular Agents > D014662 - Vasoconstrictor Agents C78272 - Agent Affecting Nervous System > C47795 - CNS Stimulant D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents D049990 - Membrane Transport Modulators

   

Piperilate

2-piperidin-1-ylethyl 2-hydroxy-2,2-diphenylacetate

C21H25NO3 (339.18343400000003)


C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent

   

2-(2-Hydroxy-4-octyloxyphenyl)-[2H]-benzotriazole

2-(2-Hydroxy-4-octyloxyphenyl)-[2H]-benzotriazole

C20H25N3O2 (339.194667)


   
   
   

Piperazine, 1-[1-[(4-chloro-2-fluorophenyl)methyl]-4-piperidinyl]-2-ethyl-, (2S)

Piperazine, 1-[1-[(4-chloro-2-fluorophenyl)methyl]-4-piperidinyl]-2-ethyl-, (2S)

C18H27ClFN3 (339.1877424)


   

Panipenem

Panipenem

C15H21N3O4S (339.1252706)


D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D013845 - Thienamycins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic

   

2-((4-(2-(PYRROLIDIN-1-YL)ETHOXY)PHENYL)AMINO)-3H-PYRROLO[2,3-D]PYRIMIDIN-4(7H)-ONE

2-((4-(2-(PYRROLIDIN-1-YL)ETHOXY)PHENYL)AMINO)-3H-PYRROLO[2,3-D]PYRIMIDIN-4(7H)-ONE

C18H21N5O2 (339.1695166)


   

4-Ethyl-3-methyl-1-phenyl-1H-indeno[1,2-b]pyrazolo[4,3-e]pyridin-5-one

4-Ethyl-3-methyl-1-phenyl-1H-indeno[1,2-b]pyrazolo[4,3-e]pyridin-5-one

C22H17N3O (339.1371552)


   

1-Methyl-3-(alpha-Cyclopentylmandeloyloxy)Pyrrolidinehydrochloride

1-Methyl-3-(alpha-Cyclopentylmandeloyloxy)Pyrrolidinehydrochloride

C18H26ClNO3 (339.16011160000005)


   

(S)-Tetrahydro-1,3,3-triphenyl-1H,3H-pyrrolo[1,2-c][1,3,2]oxaborole

(S)-Tetrahydro-1,3,3-triphenyl-1H,3H-pyrrolo[1,2-c][1,3,2]oxaborole

C23H22BNO (339.1794352)


   

Alogliptin

Alogliptin

C18H21N5O2 (339.1695166)


A - Alimentary tract and metabolism > A10 - Drugs used in diabetes > A10B - Blood glucose lowering drugs, excl. insulins > A10BH - Dipeptidyl peptidase 4 (dpp-4) inhibitors C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C98086 - Dipeptidyl Peptidase-4 Inhibitor D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D054795 - Incretins D007004 - Hypoglycemic Agents > D054873 - Dipeptidyl-Peptidase IV Inhibitors D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors C471 - Enzyme Inhibitor > C783 - Protease Inhibitor

   

Benzenepropanoic acid, 3-(2H-benzotriazol-2-yl)-5-(1,1-dimethylethyl)-4-hydroxy-

Benzenepropanoic acid, 3-(2H-benzotriazol-2-yl)-5-(1,1-dimethylethyl)-4-hydroxy-

C19H21N3O3 (339.1582836)


   

(4-(naphthalen-1-yl(phenyl)amino)phenyl)boronic acid

(4-(naphthalen-1-yl(phenyl)amino)phenyl)boronic acid

C22H18BNO2 (339.14305179999997)


   
   

2-[4-(3-phenylquinoxalin-2-yl)phenyl]propan-2-amine

2-[4-(3-phenylquinoxalin-2-yl)phenyl]propan-2-amine

C23H21N3 (339.17353860000003)


   
   

4-(4-methoxyphenyl)-2,2:6,2-terpyridine

4-(4-methoxyphenyl)-2,2:6,2-terpyridine

C22H17N3O (339.1371552)


   

6-amino-3-methyl-4-(4-methylphenyl)-1-phenylpyrazolo[3,4-b]pyridine-5-carbonitrile

6-amino-3-methyl-4-(4-methylphenyl)-1-phenylpyrazolo[3,4-b]pyridine-5-carbonitrile

C21H17N5 (339.1483882)


   

6-Bromo-4,4-dimethyl-1,4-dihydrobenzo[d][1,3]oxazin-2-one

6-Bromo-4,4-dimethyl-1,4-dihydrobenzo[d][1,3]oxazin-2-one

C21H25NO3 (339.18343400000003)


   

(2S,4R)-1-(tert-Butoxycarbonyl)-4-(2-chlorobenzyl)pyrrolidine-2-carboxylic acid

(2S,4R)-1-(tert-Butoxycarbonyl)-4-(2-chlorobenzyl)pyrrolidine-2-carboxylic acid

C17H22ClNO4 (339.1237282000001)


   

Cyprazepam

7-chloro-N-(cyclopropylmethyl)-4-hydroxy-5-phenyl-3H-1,4-benzodiazepin-2-imine

C19H18ClN3O (339.1138328)


C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent

   

azanium,cumene,furan-2,5-dione,styrene

azanium,cumene,furan-2,5-dione,styrene

C21H25NO3+ (339.18343400000003)


   

N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-L-isovaline

N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-L-isovaline

C20H21NO4 (339.14705060000006)


   

(R)-Tetrahydro-1,3,3-triphenyl-1H,3H-pyrrolo[1,2-c][1,3,2]oxaborole

(R)-Tetrahydro-1,3,3-triphenyl-1H,3H-pyrrolo[1,2-c][1,3,2]oxaborole

C23H22BNO (339.1794352)


   

3-(3-(4-(2-METHOXYETHOXY)PHENYL)ISOXAZOL-5-YL)BENZOIC ACID

3-(3-(4-(2-METHOXYETHOXY)PHENYL)ISOXAZOL-5-YL)BENZOIC ACID

C19H17NO5 (339.1106672)


   
   

4-(4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)BENZYL)MORPHOLINE HYDROCHLORIDE

4-(4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)BENZYL)MORPHOLINE HYDROCHLORIDE

C17H27BClNO3 (339.1772412)


   

4-(TERT-BUTYLAMINO)SULFONYLPHENYLBORONIC ACID PINACOL ESTER

4-(TERT-BUTYLAMINO)SULFONYLPHENYLBORONIC ACID PINACOL ESTER

C16H26BNO4S (339.1675506)


   

3-[(2-hydroxyethyl)[4-[(4-nitrophenyl)azo]phenyl]amino]propiononitrile

3-[(2-hydroxyethyl)[4-[(4-nitrophenyl)azo]phenyl]amino]propiononitrile

C17H17N5O3 (339.1331332)


   

Loxoribine

Loxoribine

C13H17N5O6 (339.1178782)


C308 - Immunotherapeutic Agent > C210 - Immunoadjuvant > C2554 - Vaccine Adjuvant C2140 - Adjuvant Loxoribine (7-Allyl-8-oxoguanosine) is a guanosine analog with anti-viral and anti-tumor activities. Loxoribine is an orally bioavailable and selective Toll-like receptor (TLR) 7 agonist[1][2][3].

   

3-hydroxy-2,3-dimethylbutan-2-yl hydrogen (2-(N-(tert-butyl)sulfamoyl)phenyl)boronate

3-hydroxy-2,3-dimethylbutan-2-yl hydrogen (2-(N-(tert-butyl)sulfamoyl)phenyl)boronate

C16H26BNO4S (339.1675506)


   

2-butyl-6-methyl-3-(4-nitrobenzyl)-3H-imidazo[4,5-b]pyridin-5-amine

2-butyl-6-methyl-3-(4-nitrobenzyl)-3H-imidazo[4,5-b]pyridin-5-amine

C18H21N5O2 (339.1695166)


   

(3R,3aR,4S,4aR,7R,8aR,9aR)-7-[(Ethoxycarbonyl)amino]-3-methyl-1-oxododecahydronaphtho[2,3-c]furan-4-carboxylic acid

(3R,3aR,4S,4aR,7R,8aR,9aR)-7-[(Ethoxycarbonyl)amino]-3-methyl-1-oxododecahydronaphtho[2,3-c]furan-4-carboxylic acid

C17H25NO6 (339.168179)


   

2-Butyl-3-(4-hydroxybenzoyl)-5-nitrobenzofuran

2-Butyl-3-(4-hydroxybenzoyl)-5-nitrobenzofuran

C19H17NO5 (339.1106672)


   

2-((6-(3-aMinopiperidin-1-yl)-3-Methyl-2,4-dioxo-3,4-dihydropyriMidin-1(2H)-yl)Methyl)benzonitrile

2-((6-(3-aMinopiperidin-1-yl)-3-Methyl-2,4-dioxo-3,4-dihydropyriMidin-1(2H)-yl)Methyl)benzonitrile

C18H21N5O2 (339.1695166)


   
   

3-(4-MORPHOLINOMETHYL)-PHENYLBORONIC ACID PINACOL ESTER HYDROCHLORIDE

3-(4-MORPHOLINOMETHYL)-PHENYLBORONIC ACID PINACOL ESTER HYDROCHLORIDE

C17H27BClNO3 (339.1772412)


   

1H-Benz[de]isoquinoline-1,3(2H)-dione,5-nitro-2-[2-(1-pyrrolidinyl)ethyl]-

1H-Benz[de]isoquinoline-1,3(2H)-dione,5-nitro-2-[2-(1-pyrrolidinyl)ethyl]-

C18H17N3O4 (339.1219002)


   

(3R,4S)-1-Benzoyl-3-(1-ethoxyethoxy)-4-phenylazetidin-2-one

(3R,4S)-1-Benzoyl-3-(1-ethoxyethoxy)-4-phenylazetidin-2-one

C20H21NO4 (339.14705060000006)


   

Sulfoxonium, dimethyl-, (3S)-3-[[(1,1-dimethylethoxy)carbonyl]amino]-2-oxo-4-phenylbutylide

Sulfoxonium, dimethyl-, (3S)-3-[[(1,1-dimethylethoxy)carbonyl]amino]-2-oxo-4-phenylbutylide

C17H25NO4S (339.15042100000005)


   

4-Cyanophenyl 4-(2-butoxyethoxy)benzoate

4-Cyanophenyl 4-(2-butoxyethoxy)benzoate

C20H21NO4 (339.14705060000006)


   

ETHYL 4-(4-PENTYLOXYBENZYLIDENEAMINO)BENZOATE

ETHYL 4-(4-PENTYLOXYBENZYLIDENEAMINO)BENZOATE

C21H25NO3 (339.18343400000003)


   

2-[3-(1,3-DIOXO-1,3-DIHYDRO-ISOINDOL-2-YL)-PROPOXY]-BENZOIC ACID METHYL ESTER

2-[3-(1,3-DIOXO-1,3-DIHYDRO-ISOINDOL-2-YL)-PROPOXY]-BENZOIC ACID METHYL ESTER

C19H17NO5 (339.1106672)


   
   

tert-Butyl (1-(2-fluoro-6-nitrophenyl)piperidin-4-yl)carbamate

tert-Butyl (1-(2-fluoro-6-nitrophenyl)piperidin-4-yl)carbamate

C16H22FN3O4 (339.15942640000003)


   

Tofimilast

Tofimilast

C18H21N5S (339.15175860000005)


C471 - Enzyme Inhibitor > C744 - Phosphodiesterase Inhibitor

   
   

Edivoxetine

Edivoxetine

C18H26FNO4 (339.18457680000006)


C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C185721 - Norepinephrine Reuptake Inhibitor C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent

   

5-Cyano-Furan-2-Carboxylic Acid [5-Hydroxymethyl-2-(4-Methyl-Piperidin-1-Yl)-Phenyl]-Amide

5-Cyano-Furan-2-Carboxylic Acid [5-Hydroxymethyl-2-(4-Methyl-Piperidin-1-Yl)-Phenyl]-Amide

C19H21N3O3 (339.1582836)


   

3-Fluoro-N-1H-indol-5-YL-5-morpholin-4-ylbenzamide

3-Fluoro-N-1H-indol-5-YL-5-morpholin-4-ylbenzamide

C19H18FN3O2 (339.138298)


   

2,4-Diamino-6-[N-(2,5-dimethoxybenzyl)-N-methylamino]quinazoline

2,4-Diamino-6-[N-(2,5-dimethoxybenzyl)-N-methylamino]quinazoline

C18H21N5O2 (339.1695166)


   
   

Lysine tyrosylquinone

Lysine tyrosylquinone

C15H21N3O6 (339.1430286)


   

(4-Fluorophenyl)-[1-(4-phenylbutyl)piperidin-4-yl]methanone

(4-Fluorophenyl)-[1-(4-phenylbutyl)piperidin-4-yl]methanone

C22H26FNO (339.1998318)


   

2-(1-azepanyl)-N-[4-(dimethylsulfamoyl)phenyl]acetamide

2-(1-azepanyl)-N-[4-(dimethylsulfamoyl)phenyl]acetamide

C16H25N3O3S (339.161654)


   

1-(2,3-Dihydro-1,4-benzodioxin-3-ylmethyl)-5-ethoxyindole-2,3-dione

1-(2,3-Dihydro-1,4-benzodioxin-3-ylmethyl)-5-ethoxyindole-2,3-dione

C19H17NO5 (339.1106672)


   

Propyromazine

Propyromazine

C20H23N2OS+ (339.1531008)


C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent

   

n2-(1-Carboxyethyl)-2-deoxyguanosine

n2-(1-Carboxyethyl)-2-deoxyguanosine

C13H17N5O6 (339.1178782)


   

Benzoic acid [[1-(4-nitrophenyl)-4-piperidinylidene]amino] ester

Benzoic acid [[1-(4-nitrophenyl)-4-piperidinylidene]amino] ester

C18H17N3O4 (339.1219002)


   

8-[(1-ethyl-3-piperidinyl)thio]-1,3-dimethyl-6-sulfanylidene-7H-purin-2-one

8-[(1-ethyl-3-piperidinyl)thio]-1,3-dimethyl-6-sulfanylidene-7H-purin-2-one

C14H21N5OS2 (339.1187456)


   

3-[[2-(6-Methoxy-3-benzofuranyl)-1-oxoethyl]amino]benzoic acid methyl ester

3-[[2-(6-Methoxy-3-benzofuranyl)-1-oxoethyl]amino]benzoic acid methyl ester

C19H17NO5 (339.1106672)


   

3-(4-methoxyphenyl)-N-methyl-5-(4-methylphenyl)-3,4-dihydropyrazole-2-carbothioamide

3-(4-methoxyphenyl)-N-methyl-5-(4-methylphenyl)-3,4-dihydropyrazole-2-carbothioamide

C19H21N3OS (339.14052560000005)


   

3-[[(3-Methoxyphenyl)-oxomethyl]amino]-2-benzofurancarboxylic acid ethyl ester

3-[[(3-Methoxyphenyl)-oxomethyl]amino]-2-benzofurancarboxylic acid ethyl ester

C19H17NO5 (339.1106672)


   

2-[3-(3-Hydroxy-3-methylbutyl)benzoyl]-1,2,3,4-tetrahydro-4-isoquinolinol

2-[3-(3-Hydroxy-3-methylbutyl)benzoyl]-1,2,3,4-tetrahydro-4-isoquinolinol

C21H25NO3 (339.18343400000003)


   

N(2)-(S)-carboxyethyl-2-deoxyguanosine

N(2)-(S)-carboxyethyl-2-deoxyguanosine

C13H17N5O6 (339.1178782)


   

N(2)-(R)-carboxyethyl-2-deoxyguanosine

N(2)-(R)-carboxyethyl-2-deoxyguanosine

C13H17N5O6 (339.1178782)


   

4-Acetoxycycloheximide

4-Acetoxycycloheximide

C17H25NO6 (339.168179)


   

6-Cyclohexylmethyloxy-2-(4-hydroxyanilino)purine

6-Cyclohexylmethyloxy-2-(4-hydroxyanilino)purine

C18H21N5O2 (339.1695166)


   

(3r,4r)-4-(Pyrrolidin-1-Ylcarbonyl)-1-(Quinoxalin-2-Ylcarbonyl)pyrrolidin-3-Amine

(3r,4r)-4-(Pyrrolidin-1-Ylcarbonyl)-1-(Quinoxalin-2-Ylcarbonyl)pyrrolidin-3-Amine

C18H21N5O2 (339.1695166)


   

1-{(1R,2S)-2-Hydroxy-1-[2-(2-naphthyloxy)ethyl]propyl}-1H-imidazone-4-carboxamide

1-{(1R,2S)-2-Hydroxy-1-[2-(2-naphthyloxy)ethyl]propyl}-1H-imidazone-4-carboxamide

C19H21N3O3 (339.1582836)


   

3-(Hydroxy-phenyl-phosphinoyloxy)-8-methyl-8-aza-bicyclo[3.2.1]octane-2-carboxylic acid methyl ester

3-(Hydroxy-phenyl-phosphinoyloxy)-8-methyl-8-aza-bicyclo[3.2.1]octane-2-carboxylic acid methyl ester

C16H22NO5P (339.1235532)


   

(2r,3r,4r,5r)-4,5-Dihydroxy-2-(Hydroxymethyl)-6-Oxopiperidin-3-Yl Beta-D-Glucopyranoside

(2r,3r,4r,5r)-4,5-Dihydroxy-2-(Hydroxymethyl)-6-Oxopiperidin-3-Yl Beta-D-Glucopyranoside

C12H21NO10 (339.1165406)


   

Pavacot

InChI=1\C20H21NO4\c1-22-17-6-5-13(10-18(17)23-2)9-16-15-12-20(25-4)19(24-3)11-14(15)7-8-21-16\h5-8,10-12H,9H2,1-4H

C20H21NO4 (339.14705060000006)


A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03A - Drugs for functional gastrointestinal disorders > A03AD - Papaverine and derivatives G - Genito urinary system and sex hormones > G04 - Urologicals > G04B - Urologicals > G04BE - Drugs used in erectile dysfunction D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids C78274 - Agent Affecting Cardiovascular System > C29707 - Vasodilating Agent D004791 - Enzyme Inhibitors > D010726 - Phosphodiesterase Inhibitors D000089162 - Genitourinary Agents > D064804 - Urological Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents C471 - Enzyme Inhibitor > C744 - Phosphodiesterase Inhibitor

   

1-(4-Pentenyl)-3-(1-naphthoyl)indole

1-(4-Pentenyl)-3-(1-naphthoyl)indole

C24H21NO (339.1623056)


   

N1-(2-aminophenyl)-N8-phenyloctanediamide

N1-(2-aminophenyl)-N8-phenyloctanediamide

C20H25N3O2 (339.194667)


D004791 - Enzyme Inhibitors > D056572 - Histone Deacetylase Inhibitors

   

N(G)-Nitroarginine-4-nitroanilide

2-amino-5-{[amino(nitroamino)methylidene]amino}-N-(4-nitrophenyl)pentanamide

C12H17N7O5 (339.1291112)


   

(2s)-1-[1-(4-Phenylbutanoyl)-L-Prolyl]pyrrolidine-2-Carbonitrile

1-[1-(4-phenylbutanoyl)pyrrolidine-2-carbonyl]pyrrolidine-2-carbonitrile

C20H25N3O2 (339.194667)


   

Panipenem

3-[(1-ethanimidoylpyrrolidin-3-yl)sulfanyl]-6-(1-hydroxyethyl)-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid

C15H21N3O4S (339.1252706)


   

3,5-dihydroxy-2-[(2E)-3-(4-hydroxyphenyl)prop-2-enoyl]-6-(3-methylbut-2-en-1-yl)phenolate

3,5-dihydroxy-2-[(2E)-3-(4-hydroxyphenyl)prop-2-enoyl]-6-(3-methylbut-2-en-1-yl)phenolate

C20H19O5- (339.12324240000004)


   
   
   

N-({(1R,2S)-2-[(2Z)-5-hydroxypent-2-en-1-yl]-3-oxocyclopentyl}acetyl)-L-isoleucine

N-({(1R,2S)-2-[(2Z)-5-hydroxypent-2-en-1-yl]-3-oxocyclopentyl}acetyl)-L-isoleucine

C18H29NO5 (339.20456240000004)


   

[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl-[3-(methylazaniumyl)propyl]azanium

[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl-[3-(methylazaniumyl)propyl]azanium

C14H25N7O3+2 (339.20187799999997)


   

9-[6(S),9-diamino-5,6,7,8,9-pentadeoxy-beta-D-ribo-nonafuranosyl]-9H-purin-6-amine

9-[6(S),9-diamino-5,6,7,8,9-pentadeoxy-beta-D-ribo-nonafuranosyl]-9H-purin-6-amine

C14H25N7O3+2 (339.20187799999997)


   

7-Hydroxy-2-(4-hydroxyphenyl)-6-(3-methylbut-2-enyl)-4-oxo-2,3-dihydrochromen-5-olate

7-Hydroxy-2-(4-hydroxyphenyl)-6-(3-methylbut-2-enyl)-4-oxo-2,3-dihydrochromen-5-olate

C20H19O5- (339.12324240000004)


   

(2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-[3-[(2S)-1-methylpyrrolidin-2-yl]pyridin-1-ium-1-yl]oxane-2-carboxylic acid

(2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-[3-[(2S)-1-methylpyrrolidin-2-yl]pyridin-1-ium-1-yl]oxane-2-carboxylic acid

C16H23N2O6+ (339.1556038)


   

2-[1-[(4-Amino-2-methylpyrimidin-5-yl)methyl]-2-methylpyridin-1-ium-3-yl]ethyl dihydrogen phosphate

2-[1-[(4-Amino-2-methylpyrimidin-5-yl)methyl]-2-methylpyridin-1-ium-3-yl]ethyl dihydrogen phosphate

C14H20N4O4P+ (339.12221100000005)


   

2-amino-9-[3,4-dihydroxy-5-(hydroxymethyl)-2-oxolanyl]-7-prop-2-enyl-3H-purine-6,8-dione

2-amino-9-[3,4-dihydroxy-5-(hydroxymethyl)-2-oxolanyl]-7-prop-2-enyl-3H-purine-6,8-dione

C13H17N5O6 (339.1178782)


   

2-[[9-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-oxo-1H-purin-2-yl]amino]propanoic acid

2-[[9-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-oxo-1H-purin-2-yl]amino]propanoic acid

C13H17N5O6 (339.1178782)


   

Deca-2,5,8-trienedioylcarnitine

Deca-2,5,8-trienedioylcarnitine

C17H25NO6 (339.168179)


   

Deca-3,5,7-trienedioylcarnitine

Deca-3,5,7-trienedioylcarnitine

C17H25NO6 (339.168179)


   

Deca-4,6,8-trienedioylcarnitine

Deca-4,6,8-trienedioylcarnitine

C17H25NO6 (339.168179)


   

(3E,5E,8Z)-Deca-3,5,8-trienedioylcarnitine

(3E,5E,8Z)-Deca-3,5,8-trienedioylcarnitine

C17H25NO6 (339.168179)


   

N-(4-chlorophenyl)-5-methyl-2-[(4-methylphenyl)methyl]-3-pyrazolecarboxamide

N-(4-chlorophenyl)-5-methyl-2-[(4-methylphenyl)methyl]-3-pyrazolecarboxamide

C19H18ClN3O (339.1138328)


   

sophoraflavanone B(1-)

sophoraflavanone B(1-)

C20H19O5- (339.12324240000004)


Conjugate base of sophoraflavanone B arising from deprotonation of the 7-hydroxy group.

   

(2S)-2-amino-N-[(2S)-1-[[(2S)-4-chloro-3-oxo-1-phenylbutan-2-yl]amino]-1-oxopropan-2-yl]propanamide

(2S)-2-amino-N-[(2S)-1-[[(2S)-4-chloro-3-oxo-1-phenylbutan-2-yl]amino]-1-oxopropan-2-yl]propanamide

C16H22ClN3O3 (339.1349612)


D009676 - Noxae > D000477 - Alkylating Agents > D000590 - Amino Acid Chloromethyl Ketones

   

3-(Dimethylamino)benzoic acid (7-hydroxy-2-oxo-1-benzopyran-4-yl)methyl ester

3-(Dimethylamino)benzoic acid (7-hydroxy-2-oxo-1-benzopyran-4-yl)methyl ester

C19H17NO5 (339.1106672)


   

2-[[4-(2,4-Dimethylphenyl)-5-(3-pyridinyl)-1,2,4-triazol-3-yl]thio]acetamide

2-[[4-(2,4-Dimethylphenyl)-5-(3-pyridinyl)-1,2,4-triazol-3-yl]thio]acetamide

C17H17N5OS (339.1153752)


   
   

(2S)-2-[[(2S,3S)-2-[[(2S)-2-aminopropanoyl]amino]-3-methylpentanoyl]amino]-3-(1H-imidazol-5-yl)propanoic acid

(2S)-2-[[(2S,3S)-2-[[(2S)-2-aminopropanoyl]amino]-3-methylpentanoyl]amino]-3-(1H-imidazol-5-yl)propanoic acid

C15H25N5O4 (339.190645)


   

5-(4-Fluorophenyl)-7-(3-methoxyphenyl)-1,5,6,7-tetrahydro-[1,2,4]triazolo[1,5-a]pyrimidin-2-amine

5-(4-Fluorophenyl)-7-(3-methoxyphenyl)-1,5,6,7-tetrahydro-[1,2,4]triazolo[1,5-a]pyrimidin-2-amine

C18H18FN5O (339.149531)


   

4-benzyl-N-(2,4-dimethylphenyl)piperazine-1-carbothioamide

4-benzyl-N-(2,4-dimethylphenyl)piperazine-1-carbothioamide

C20H25N3S (339.176909)


   

4-[4-(3-Methoxyphenyl)-6-(trifluoromethyl)-2-pyrimidinyl]morpholine

4-[4-(3-Methoxyphenyl)-6-(trifluoromethyl)-2-pyrimidinyl]morpholine

C16H16F3N3O2 (339.1194552)


   

1-(3-Cyano-7-methoxy-2-quinolinyl)-4-piperidinecarboxylic acid ethyl ester

1-(3-Cyano-7-methoxy-2-quinolinyl)-4-piperidinecarboxylic acid ethyl ester

C19H21N3O3 (339.1582836)


   

N-(5-methyl-7-phenyl-1,5,6,7-tetrahydro-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)-2-thiophenecarboxamide

N-(5-methyl-7-phenyl-1,5,6,7-tetrahydro-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)-2-thiophenecarboxamide

C17H17N5OS (339.1153752)


   

N-[(1E)-(3-allyl-2-hydroxyphenyl)methylene]-2-[(2-methoxyphenyl)amino]acetohydrazide

N-[(1E)-(3-allyl-2-hydroxyphenyl)methylene]-2-[(2-methoxyphenyl)amino]acetohydrazide

C19H21N3O3 (339.1582836)


   

N-hydroxy-N-[(E)-(4-phenylphenyl)methylideneamino]hexanediamide

N-hydroxy-N-[(E)-(4-phenylphenyl)methylideneamino]hexanediamide

C19H21N3O3 (339.1582836)


   

1-(3-Chloro-4-fluorophenyl)-4-[(4-methyl-1-piperazinyl)-oxomethyl]-2-pyrrolidinone

1-(3-Chloro-4-fluorophenyl)-4-[(4-methyl-1-piperazinyl)-oxomethyl]-2-pyrrolidinone

C16H19ClFN3O2 (339.1149756)


   

(1R,2R,3S,5S)-3-(benzoyloxy)-2-(methoxycarbonyl)-8-methyl-8-azoniabicyclo[3.2.1]octane chloride

(1R,2R,3S,5S)-3-(benzoyloxy)-2-(methoxycarbonyl)-8-methyl-8-azoniabicyclo[3.2.1]octane chloride

C17H22ClNO4 (339.1237282000001)


   

N-[1-(1-hexyl-2-benzimidazolyl)ethyl]-2-furancarboxamide

N-[1-(1-hexyl-2-benzimidazolyl)ethyl]-2-furancarboxamide

C20H25N3O2 (339.194667)


   

3-(Phenoxymethyl)-2-benzofurancarboxylic acid (1-amino-1-oxopropan-2-yl) ester

3-(Phenoxymethyl)-2-benzofurancarboxylic acid (1-amino-1-oxopropan-2-yl) ester

C19H17NO5 (339.1106672)


   

1-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-2-phenyl-1-butanone

1-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-2-phenyl-1-butanone

C21H25NO3 (339.18343400000003)


   

2-[3-cyano-4-(methoxymethyl)-6-methyl-2-oxo-1-pyridinyl]-N-(3,5-dimethylphenyl)acetamide

2-[3-cyano-4-(methoxymethyl)-6-methyl-2-oxo-1-pyridinyl]-N-(3,5-dimethylphenyl)acetamide

C19H21N3O3 (339.1582836)


   

N-(3,4-dimethylphenyl)-2-[(5-pyridin-4-yl-1H-1,2,4-triazol-3-yl)thio]acetamide

N-(3,4-dimethylphenyl)-2-[(5-pyridin-4-yl-1H-1,2,4-triazol-3-yl)thio]acetamide

C17H17N5OS (339.1153752)


   

3-(4-tert-butylphenyl)-4-[(E)-(1-methylpyrrol-2-yl)methylideneamino]-1H-1,2,4-triazole-5-thione

3-(4-tert-butylphenyl)-4-[(E)-(1-methylpyrrol-2-yl)methylideneamino]-1H-1,2,4-triazole-5-thione

C18H21N5S (339.15175860000005)


   

N-[2-[2-(dibutylamino)ethylamino]-2-oxoethyl]-2-thiophenecarboxamide

N-[2-[2-(dibutylamino)ethylamino]-2-oxoethyl]-2-thiophenecarboxamide

C17H29N3O2S (339.19803740000003)


   

4-Hydroxy-1,7,7-trimethyl-3-(2,4,6-trimethylphenyl)-6,8-dihydroquinoline-2,5-dione

4-Hydroxy-1,7,7-trimethyl-3-(2,4,6-trimethylphenyl)-6,8-dihydroquinoline-2,5-dione

C21H25NO3 (339.18343400000003)


   

8-Methyl-1-[2-(2-methylpiperidin-1-yl)-2-oxoethyl]chromeno[4,3-c]pyrazol-4-one

8-Methyl-1-[2-(2-methylpiperidin-1-yl)-2-oxoethyl]chromeno[4,3-c]pyrazol-4-one

C19H21N3O3 (339.1582836)


   

2-[1-[(2-chloro-6-fluorophenyl)methyl]-3-oxo-2-piperazinyl]-N-prop-2-enylacetamide

2-[1-[(2-chloro-6-fluorophenyl)methyl]-3-oxo-2-piperazinyl]-N-prop-2-enylacetamide

C16H19ClFN3O2 (339.1149756)


   

N-[(E)-1-(3-Acetamidophenyl)ethylideneamino]-1,3-benzodioxole-5-carboxamide

N-[(E)-1-(3-Acetamidophenyl)ethylideneamino]-1,3-benzodioxole-5-carboxamide

C18H17N3O4 (339.1219002)


   

8-Benzyl-4-pyridin-2-yl-1-thia-4,8-diazaspiro[4.5]decan-3-one

8-Benzyl-4-pyridin-2-yl-1-thia-4,8-diazaspiro[4.5]decan-3-one

C19H21N3OS (339.14052560000005)


   
   
   
   
   
   
   
   
   
   
   

1-(2-Methyl-4-benzofuro[3,2-d]pyrimidinyl)-3-piperidinecarboxylic acid ethyl ester

1-(2-Methyl-4-benzofuro[3,2-d]pyrimidinyl)-3-piperidinecarboxylic acid ethyl ester

C19H21N3O3 (339.1582836)


   

N-(4-cyclohexylphenyl)-2-(4-methylphenyl)sulanylacetamide

N-(4-cyclohexylphenyl)-2-(4-methylphenyl)sulanylacetamide

C21H25NOS (339.165676)


   

4-[4-[(4-Methoxyphenyl)methyl]-1-piperidinyl]thieno[2,3-d]pyrimidine

4-[4-[(4-Methoxyphenyl)methyl]-1-piperidinyl]thieno[2,3-d]pyrimidine

C19H21N3OS (339.14052560000005)


   

(5E)-5-[(1-benzyl-2,5-dimethylpyrrol-3-yl)methylidene]-3-methyl-2-methylimino-1,3-thiazolidin-4-one

(5E)-5-[(1-benzyl-2,5-dimethylpyrrol-3-yl)methylidene]-3-methyl-2-methylimino-1,3-thiazolidin-4-one

C19H21N3OS (339.14052560000005)


   

2-(1,1-Dimethylpiperidin-1-ium-3-yl)oxy-2-oxo-1,1-diphenylethanolate

2-(1,1-Dimethylpiperidin-1-ium-3-yl)oxy-2-oxo-1,1-diphenylethanolate

C21H25NO3 (339.18343400000003)


   

(2R,3S,4S)-1-(4-ethyl-1,3-thiazol-2-yl)-4-(hydroxymethyl)-3-[4-[(E)-prop-1-enyl]phenyl]azetidine-2-carbonitrile

(2R,3S,4S)-1-(4-ethyl-1,3-thiazol-2-yl)-4-(hydroxymethyl)-3-[4-[(E)-prop-1-enyl]phenyl]azetidine-2-carbonitrile

C19H21N3OS (339.14052560000005)


   

(2S,3S,4R)-1-(4-ethyl-1,3-thiazol-2-yl)-4-(hydroxymethyl)-3-[4-[(E)-prop-1-enyl]phenyl]azetidine-2-carbonitrile

(2S,3S,4R)-1-(4-ethyl-1,3-thiazol-2-yl)-4-(hydroxymethyl)-3-[4-[(E)-prop-1-enyl]phenyl]azetidine-2-carbonitrile

C19H21N3OS (339.14052560000005)


   

(2S,3R,4R)-1-(4-ethyl-1,3-thiazol-2-yl)-4-(hydroxymethyl)-3-[4-[(E)-prop-1-enyl]phenyl]azetidine-2-carbonitrile

(2S,3R,4R)-1-(4-ethyl-1,3-thiazol-2-yl)-4-(hydroxymethyl)-3-[4-[(E)-prop-1-enyl]phenyl]azetidine-2-carbonitrile

C19H21N3OS (339.14052560000005)


   

(2S,3R,4S)-1-(4-ethyl-1,3-thiazol-2-yl)-4-(hydroxymethyl)-3-[4-[(E)-prop-1-enyl]phenyl]azetidine-2-carbonitrile

(2S,3R,4S)-1-(4-ethyl-1,3-thiazol-2-yl)-4-(hydroxymethyl)-3-[4-[(E)-prop-1-enyl]phenyl]azetidine-2-carbonitrile

C19H21N3OS (339.14052560000005)


   

(2S,3S,4S)-1-(4-ethyl-1,3-thiazol-2-yl)-4-(hydroxymethyl)-3-[4-[(E)-prop-1-enyl]phenyl]azetidine-2-carbonitrile

(2S,3S,4S)-1-(4-ethyl-1,3-thiazol-2-yl)-4-(hydroxymethyl)-3-[4-[(E)-prop-1-enyl]phenyl]azetidine-2-carbonitrile

C19H21N3OS (339.14052560000005)


   

1-[(2S,3S,4R)-2-(ethylaminomethyl)-4-(hydroxymethyl)-3-phenyl-1-azetidinyl]-2-(2-pyridinyl)ethanone

1-[(2S,3S,4R)-2-(ethylaminomethyl)-4-(hydroxymethyl)-3-phenyl-1-azetidinyl]-2-(2-pyridinyl)ethanone

C20H25N3O2 (339.194667)


   

3-(benzotriazol-1-yl)-N-[(E)-(2-hydroxy-5-methoxyphenyl)methylideneamino]propanamide

3-(benzotriazol-1-yl)-N-[(E)-(2-hydroxy-5-methoxyphenyl)methylideneamino]propanamide

C17H17N5O3 (339.1331332)


   

N-hydroxy-N-[(E)-(4-hydroxy-2,6-dimethoxyphenyl)methylideneamino]hexanediamide

N-hydroxy-N-[(E)-(4-hydroxy-2,6-dimethoxyphenyl)methylideneamino]hexanediamide

C15H21N3O6 (339.1430286)


   

(2R,3R,4S)-1-(4-ethyl-1,3-thiazol-2-yl)-4-(hydroxymethyl)-3-[4-[(E)-prop-1-enyl]phenyl]azetidine-2-carbonitrile

(2R,3R,4S)-1-(4-ethyl-1,3-thiazol-2-yl)-4-(hydroxymethyl)-3-[4-[(E)-prop-1-enyl]phenyl]azetidine-2-carbonitrile

C19H21N3OS (339.14052560000005)


   

(2R,3R,4R)-1-(4-ethyl-1,3-thiazol-2-yl)-4-(hydroxymethyl)-3-[4-[(E)-prop-1-enyl]phenyl]azetidine-2-carbonitrile

(2R,3R,4R)-1-(4-ethyl-1,3-thiazol-2-yl)-4-(hydroxymethyl)-3-[4-[(E)-prop-1-enyl]phenyl]azetidine-2-carbonitrile

C19H21N3OS (339.14052560000005)


   

1-[(2R,3R,4S)-2-(ethylaminomethyl)-4-(hydroxymethyl)-3-phenyl-1-azetidinyl]-2-(2-pyridinyl)ethanone

1-[(2R,3R,4S)-2-(ethylaminomethyl)-4-(hydroxymethyl)-3-phenyl-1-azetidinyl]-2-(2-pyridinyl)ethanone

C20H25N3O2 (339.194667)


   

1-[(2S,3R,4S)-2-(ethylaminomethyl)-4-(hydroxymethyl)-3-phenyl-1-azetidinyl]-2-(2-pyridinyl)ethanone

1-[(2S,3R,4S)-2-(ethylaminomethyl)-4-(hydroxymethyl)-3-phenyl-1-azetidinyl]-2-(2-pyridinyl)ethanone

C20H25N3O2 (339.194667)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

Estra-1,3,5(10)-triene-16,17-dione, 3-(2-propenyloxy)-, 16-oxime

Estra-1,3,5(10)-triene-16,17-dione, 3-(2-propenyloxy)-, 16-oxime

C21H25NO3 (339.18343400000003)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones

   

PF-670462 free base(2+)

PF-670462 free base(2+)

C19H22FN5+2 (339.1859144)


   
   
   
   

N-({(1R)-2-[(2Z)-5-hydroxypent-2-en-1-yl]-3-oxocyclopentyl}acetyl)-L-isoleucine

N-({(1R)-2-[(2Z)-5-hydroxypent-2-en-1-yl]-3-oxocyclopentyl}acetyl)-L-isoleucine

C18H29NO5 (339.20456240000004)


   

6-tert-butyl-N-[(E)-pyridin-4-ylmethylideneamino]-2,3-dihydro-1,4-benzodioxine-3-carboxamide

6-tert-butyl-N-[(E)-pyridin-4-ylmethylideneamino]-2,3-dihydro-1,4-benzodioxine-3-carboxamide

C19H21N3O3 (339.1582836)


   

6-tert-butyl-N-[(E)-pyridin-2-ylmethylideneamino]-2,3-dihydro-1,4-benzodioxine-3-carboxamide

6-tert-butyl-N-[(E)-pyridin-2-ylmethylideneamino]-2,3-dihydro-1,4-benzodioxine-3-carboxamide

C19H21N3O3 (339.1582836)


   

1-[(1S,2S)-2-[(3-chlorophenyl)methoxy]-1,2,3,4-tetrahydronaphthalen-1-yl]triazole

1-[(1S,2S)-2-[(3-chlorophenyl)methoxy]-1,2,3,4-tetrahydronaphthalen-1-yl]triazole

C19H18ClN3O (339.1138328)


   

2-(5-cyano-1,4-dimethyl-6-oxopyridin-2-yl)oxy-N-(4-propan-2-ylphenyl)acetamide

2-(5-cyano-1,4-dimethyl-6-oxopyridin-2-yl)oxy-N-(4-propan-2-ylphenyl)acetamide

C19H21N3O3 (339.1582836)


   

4-(3-Acetyl-9-phenanthryl)-N,N-dimethylaniline

4-(3-Acetyl-9-phenanthryl)-N,N-dimethylaniline

C24H21NO (339.1623056)


   

PERAZINE

PERAZINE

C20H25N3S (339.176909)


N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AB - Phenothiazines with piperazine structure D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C66883 - Dopamine Antagonist

   

(6aR,9R)-N-[(2S)-1-hydroxybutan-2-yl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide

(6aR,9R)-N-[(2S)-1-hydroxybutan-2-yl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide

C20H25N3O2 (339.194667)


   

desmethylxanthohumol(1-)

desmethylxanthohumol(1-)

C20H19O5 (339.12324240000004)


A phenolate anion that is the conjugate base of xanthohumol, obtained by deprotonation of the 1-hydroxy group. It is the major microspecies at pH 7.3 (according to Marvin v 6.2.0.).

   
   

Methylhydroxygliclazide

Methylhydroxygliclazide

C15H21N3O4S (339.1252706)


   
   

Methergine

Methergine

C20H25N3O2 (339.194667)


D012102 - Reproductive Control Agents > D010120 - Oxytocics

   

5-(N(6)-L-lysine)-L-tyrosylquinone

5-(N(6)-L-lysine)-L-tyrosylquinone

C15H21N3O6 (339.1430286)


An L-lysine derivative in which one of the amino hydrogens at N(6)-amino is substituted by a 6-[(2S)-2-amino-2-carboxyethyl]-3,4-dioxocyclohexa-1,5-dien-1-yl group.

   

3-(2-Propenyloxy)estra-1,3,5(10)-triene-16,17-dione 16-oxime

Estra-1,3,5(10)-triene-16,17-dione, 3-(2-propenyloxy)-, 16-oxime

C21H25NO3 (339.18343400000003)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones

   

N-(1-hydroxybutan-2-yl)-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide

N-(1-hydroxybutan-2-yl)-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide

C20H25N3O2 (339.194667)


   

N-[(+)-12-hydroxy-7-isojasmonyl]isoleucine

N-[(+)-12-hydroxy-7-isojasmonyl]isoleucine

C18H29NO5 (339.20456240000004)


An L-isoleucine derivative resulting from the formal condensation of the carboxy group of (+)-12-hydroxy-7-isojasmonic acid with the amino group of L-isoleucine.

   

perivine(1+)

perivine(1+)

C20H23N2O3 (339.1708588)


A secondary ammonium ion that is the conjugate acid of perivine obtained by protonation of the secondary amino group; major species at pH 7.3.

   

O-hydroxy(phenyl)phosphinoyl ecgonine methyl ester

O-hydroxy(phenyl)phosphinoyl ecgonine methyl ester

C16H22NO5P (339.1235532)


The O-hydroxy(phenyl)phosphinoyl derivative of ecgonine methyl ester.

   

2-Methyl-3-morpholino-1,1-diphenylpropane-carboxylic acid

2-Methyl-3-morpholino-1,1-diphenylpropane-carboxylic acid

C21H25NO3 (339.18343400000003)


   
   
   

Aptiganel (hydrochloride)

Aptiganel (hydrochloride)

C20H22ClN3 (339.15021620000005)


Aptiganel hydrochloride (Cerestat) is a non-competitive NMDA receptor antagonist with neuroprotective effect.

   

HJC0197

HJC0197

C19H21N3OS (339.14052560000005)


HJC0197 is a potent Epac1 (exchange protein directly activated by cAMP 1) and Epac2 (IC50=5.9 μM for Epac2) antagonist. HJC0197 selectively blocks cAMP-induced Epac activation. HJC0197 inhibits Epac1-mediated Rap1-GDP exchange activity at 25 μM in the presence of equal concentration of cAMP[1].

   

KYP-2047

KYP-2047

C20H25N3O2 (339.194667)


KYP-2047 is a potent and BBB-penetrating prolyl-oligopeptidase (POP) inhibitor, with an Ki value of 0.023 nM. KYP-2047 reduces glioblastoma proliferation through angiogenesis and apoptosis modulation[1][2].

   

SEN12333

SEN12333

C20H25N3O2 (339.194667)


SEN 12333 (WAY-317538) is a potent, selective and orally active α7 nAChR agonist. SEN12333 displays high affinity for the rat α7 nAChRs expressed in GH4C1 cells (K>i=260 nM) and acts as full agonist in functional Ca2+ flux studies (EC50=1.6 μM). SEN 12333 is used for AD and schizophrenia research[1].

   

SIBA

SIBA

C14H21N5O3S (339.1365036000001)


SIBA (5'-Isobutylthioadenosine) is a transmethylation inhibitor (SAH (HY-19528) analogue), with potent anti-proliferative activity. SIBA reversibly inhibits the production of HSV-1 by blocking methylation, specifically by blocking the 5' end-capping of viral mRNA. SIBA also inhibits the growth of tumour cells in vitro and metastatic spread in vivo. SIBA can be used in cancer, HSV-1 infection and anti-malaria studies[1][2][3].

   

VU6010572

VU6010572

C20H18FNO3 (339.127065)


VU6010572 is a potent and selective mGlu3 negative allosteric modulator with IC50 of 245 nM. VU6010572 is highly CNS penetrant[1][2].

   

10-chloro-2,2-dimethyl-5-methylidenedeca-7,9-dien-3-yl 1-methylpyrrolidine-2-carboxylate

10-chloro-2,2-dimethyl-5-methylidenedeca-7,9-dien-3-yl 1-methylpyrrolidine-2-carboxylate

C19H30ClNO2 (339.196495)


   

3,10-dihydroxy-2,4-dimethoxy-7,8-dihydro-6-azatetraphen-5-one

3,10-dihydroxy-2,4-dimethoxy-7,8-dihydro-6-azatetraphen-5-one

C19H17NO5 (339.1106672)


   

17,18-dimethoxy-11-methyl-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8(20),14,16,18-hexaene

17,18-dimethoxy-11-methyl-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8(20),14,16,18-hexaene

C20H21NO4 (339.14705060000006)


   

(13r)-16,17-dimethoxy-5,7-dioxa-1-azapentacyclo[11.8.0.0³,¹¹.0⁴,⁸.0¹⁴,¹⁹]henicosa-3,8,10,14(19),15,17-hexaene

(13r)-16,17-dimethoxy-5,7-dioxa-1-azapentacyclo[11.8.0.0³,¹¹.0⁴,⁸.0¹⁴,¹⁹]henicosa-3,8,10,14(19),15,17-hexaene

C20H21NO4 (339.14705060000006)


   

18,19-dimethoxy-13-methyl-5,7-dioxa-13-azapentacyclo[10.7.1.0²,¹⁰.0⁴,⁸.0¹⁶,²⁰]icosa-1(19),2,4(8),9,16(20),17-hexaene

18,19-dimethoxy-13-methyl-5,7-dioxa-13-azapentacyclo[10.7.1.0²,¹⁰.0⁴,⁸.0¹⁶,²⁰]icosa-1(19),2,4(8),9,16(20),17-hexaene

C20H21NO4 (339.14705060000006)


   

(1r,12s)-23-methyl-5,7,16,18-tetraoxa-23-azahexacyclo[10.10.1.0²,¹⁰.0⁴,⁸.0¹³,²¹.0¹⁵,¹⁹]tricosa-2,4(8),9,13,15(19),20-hexaen-1-ol

(1r,12s)-23-methyl-5,7,16,18-tetraoxa-23-azahexacyclo[10.10.1.0²,¹⁰.0⁴,⁸.0¹³,²¹.0¹⁵,¹⁹]tricosa-2,4(8),9,13,15(19),20-hexaen-1-ol

C19H17NO5 (339.1106672)


   

2-methoxy-5-methyl-6-[(1e,3e)-3-methyl-4-(1h-pyrrol-2-yl)buta-1,3-dien-1-yl]-3-(2-methylbut-3-en-2-yl)pyran-4-one

2-methoxy-5-methyl-6-[(1e,3e)-3-methyl-4-(1h-pyrrol-2-yl)buta-1,3-dien-1-yl]-3-(2-methylbut-3-en-2-yl)pyran-4-one

C21H25NO3 (339.18343400000003)


   

4-(1h-indol-3-yl)-6-(1h-indol-3-ylmethyl)pyridin-3-ol

4-(1h-indol-3-yl)-6-(1h-indol-3-ylmethyl)pyridin-3-ol

C22H17N3O (339.1371552)


   

15,16-dimethoxy-8,10-dimethyl-11-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2(7),3,5,8,13,15-heptaene-5,14-diol

15,16-dimethoxy-8,10-dimethyl-11-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2(7),3,5,8,13,15-heptaene-5,14-diol

C20H21NO4 (339.14705060000006)


   

(1r,24r)-5,7,17,19-tetraoxa-13-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁵,²³.0¹⁶,²⁰]tetracosa-2,4(8),9,15,20,22-hexaen-24-ol

(1r,24r)-5,7,17,19-tetraoxa-13-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁵,²³.0¹⁶,²⁰]tetracosa-2,4(8),9,15,20,22-hexaen-24-ol

C19H17NO5 (339.1106672)


   

(6z)-3-methyl-6-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methylidene}pyrazine-2,3,5-triol

(6z)-3-methyl-6-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methylidene}pyrazine-2,3,5-triol

C19H21N3O3 (339.1582836)


   

(12r)-16,17-dimethoxy-11-methyl-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8(20),14(19),15,17-hexaene

(12r)-16,17-dimethoxy-11-methyl-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8(20),14(19),15,17-hexaene

C20H21NO4 (339.14705060000006)


   

17-hydroxy-16-methoxy-5,7-dioxa-13-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁵,²⁰]henicosa-2,4(8),9,15(20),16,18-hexaen-14-one

17-hydroxy-16-methoxy-5,7-dioxa-13-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁵,²⁰]henicosa-2,4(8),9,15(20),16,18-hexaen-14-one

C19H17NO5 (339.1106672)


   

methyl (9r)-15,16-dimethoxy-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2,4,6,13,15-hexaene-10-carboxylate

methyl (9r)-15,16-dimethoxy-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2,4,6,13,15-hexaene-10-carboxylate

C20H21NO4 (339.14705060000006)


   

6,7,11-trihydroxy-2,2,5-trimethyl-1-oxa-5-azatetraphen-10-one

6,7,11-trihydroxy-2,2,5-trimethyl-1-oxa-5-azatetraphen-10-one

C19H17NO5 (339.1106672)


   

(12s,13s)-13,16-dimethoxy-11-methyl-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8(20),14,16,18-hexaene

(12s,13s)-13,16-dimethoxy-11-methyl-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8(20),14,16,18-hexaene

C20H21NO4 (339.14705060000006)


   

(1s,3r,5r,6r,7s)-6-hydroxy-8-methyl-7-[(3-methylbutanoyl)oxy]-8-azabicyclo[3.2.1]octan-3-yl (2e)-2-methylbut-2-enoate

(1s,3r,5r,6r,7s)-6-hydroxy-8-methyl-7-[(3-methylbutanoyl)oxy]-8-azabicyclo[3.2.1]octan-3-yl (2e)-2-methylbut-2-enoate

C18H29NO5 (339.20456240000004)


   

(7e,9e)-10-chloro-2,2-dimethyl-5-methylidenedeca-7,9-dien-3-yl (2s)-1-methylpyrrolidine-2-carboxylate

(7e,9e)-10-chloro-2,2-dimethyl-5-methylidenedeca-7,9-dien-3-yl (2s)-1-methylpyrrolidine-2-carboxylate

C19H30ClNO2 (339.196495)


   

23-methyl-5,7,16,18-tetraoxa-23-azahexacyclo[10.10.1.0²,¹⁰.0⁴,⁸.0¹³,²¹.0¹⁵,¹⁹]tricosa-2,4(8),9,13,15(19),20-hexaen-1-ol

23-methyl-5,7,16,18-tetraoxa-23-azahexacyclo[10.10.1.0²,¹⁰.0⁴,⁸.0¹³,²¹.0¹⁵,¹⁹]tricosa-2,4(8),9,13,15(19),20-hexaen-1-ol

C19H17NO5 (339.1106672)


   

9-(2h-1,3-benzodioxol-5-yl)-1-(piperidin-1-yl)nona-2,4,8-trien-1-one

9-(2h-1,3-benzodioxol-5-yl)-1-(piperidin-1-yl)nona-2,4,8-trien-1-one

C21H25NO3 (339.18343400000003)


   

4,5,16-trimethoxy-11-methyl-2-oxa-11-azatetracyclo[8.6.1.0³,⁸.0¹³,¹⁷]heptadeca-1(16),3,5,7,9,13(17),14-heptaen-12-one

4,5,16-trimethoxy-11-methyl-2-oxa-11-azatetracyclo[8.6.1.0³,⁸.0¹³,¹⁷]heptadeca-1(16),3,5,7,9,13(17),14-heptaen-12-one

C19H17NO5 (339.1106672)


   

(1s,10z)-6-hydroxy-4,5,6,13-tetramethyl-2,8-dioxa-13-azabicyclo[8.5.1]hexadec-10-ene-3,7,16-trione

(1s,10z)-6-hydroxy-4,5,6,13-tetramethyl-2,8-dioxa-13-azabicyclo[8.5.1]hexadec-10-ene-3,7,16-trione

C17H25NO6 (339.168179)


   

17-methoxy-12-methyl-5,7-dioxa-1-azapentacyclo[11.8.0.0³,¹¹.0⁴,⁸.0¹⁴,¹⁹]henicosa-3,8,10,14(19),15,17-hexaen-16-ol

17-methoxy-12-methyl-5,7-dioxa-1-azapentacyclo[11.8.0.0³,¹¹.0⁴,⁸.0¹⁴,¹⁹]henicosa-3,8,10,14(19),15,17-hexaen-16-ol

C20H21NO4 (339.14705060000006)